64
Participants
Start Date
June 30, 2011
Primary Completion Date
June 30, 2013
Study Completion Date
December 31, 2032
Model 10642 Implantable Intravascular Catheter
This clinical study consists of the Model 10642 Implantable Intravascular Catheter used in combination with the SynchroMed II Implantable Infusion System (Model 8637) to deliver Remodulin Injection. This study will focus on the safety of delivery of Remodulin Injection in the treatment of patients with PAH who meet the approved Remodulin Injection indication, using the approved formulation, and approved intravenous route of administration.
AdventHealth Orlando, Orlando
University of Alabama at Birmingham, Birmingham
Aurora St. Lukes Medical Center, Milwaukee
Mayo Clinic, Rochester
University of Chicago Medical Center, Chicago
VA Greater Los Angeles Healthcare System, Los Angeles
Brigham & Women's Hospital, Boston
University of Texas Southwestern Medical Center, Dallas
Collaborators (1)
United Therapeutics
INDUSTRY
Medtronic Cardiac Rhythm and Heart Failure
INDUSTRY